Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PanTheryx is a biotechnology and medical nutrition company dedicated to realizing the therapeutic potential of bovine colostrum for human health. The company utilizes a proprietary technology platform to produce high-quality colostrum that preserves essential bioactive components, such as immunoglobulins and growth factors, which support the digestive and immune systems. PanTheryx's commercial portfolio includes the TruBiotics probiotic brand and DiaResQ, a medical food recognized by the United Nations for its potential to address global infectious diarrhea. Based in Boulder, Colorado, the company serves consumer, healthcare practitioner, and institutional markets worldwide. In 2023, PanTheryx divested its B2B bioactive ingredients business to Glanbia Nutritionals to focus on its core consumer brands and clinical research initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PanTherix.